Replimune TUDRIQEV FDA Accelerated Approval Investor Call Aug 6, 2026 4:30 PM EDT Click here for webcast Supporting Materials Replimune TUDRIQEV FDA Accelerated Approval Investor Call Presentation 1.2 MB